Search Results
Search for other papers by Faith Nutter in
Google Scholar
PubMed
Search for other papers by Ingunn Holen in
Google Scholar
PubMed
Search for other papers by Hannah K Brown in
Google Scholar
PubMed
Search for other papers by Simon S Cross in
Google Scholar
PubMed
Search for other papers by C Alyson Evans in
Google Scholar
PubMed
Search for other papers by Matthew Walker in
Google Scholar
PubMed
Search for other papers by Robert E Coleman in
Google Scholar
PubMed
Search for other papers by Jules A Westbrook in
Google Scholar
PubMed
Search for other papers by Peter J Selby in
Google Scholar
PubMed
Academic Unit of Clinical Oncology, Academic Unit of Pathology, Leeds Institute of Molecular Medicine, Cancer Research UK (CR‐UK), and Yorkshire Cancer Research (YCR) Sheffield Cancer Research Centre
Search for other papers by Janet E Brown in
Google Scholar
PubMed
Search for other papers by Penelope D Ottewell in
Google Scholar
PubMed
-IV tumours at any point over a 30 day time period, mean tumour area of 4.4±1.1 mm 2 being recorded for MDA-P cells and 3.4±1.7 mm 2 for MDA-IV cells at 35 days ( Fig. 3 c). Genetic alterations associated with bone-homing Intravenous injection of MDA
Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Search for other papers by Ali S Alzahrani in
Google Scholar
PubMed
Search for other papers by Meshael Alswailem in
Google Scholar
PubMed
Département de Médecine Génomique des Tumeurs et des Cancers, Fédération de Génétique et de Médecine Génomique, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Alexandre Buffet in
Google Scholar
PubMed
Search for other papers by Balgees Alghamdi in
Google Scholar
PubMed
Search for other papers by Lulu Alobaid in
Google Scholar
PubMed
Search for other papers by Osamah Alsagheir in
Google Scholar
PubMed
Search for other papers by Hindi Al-Hindi in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
approximately additional 30% of PPGLs carry somatic or postzygotic pathogenic variants ( Fishbein et al. 2017 , Nölting et al. 2021 ). These genetic alterations have been classified into at least three clusters based on their gene expression profiles
Search for other papers by Tanner Freeman in
Google Scholar
PubMed
Search for other papers by Charit Taneja in
Google Scholar
PubMed
Search for other papers by N Paul Ohori in
Google Scholar
PubMed
Search for other papers by Abigail I Wald in
Google Scholar
PubMed
Search for other papers by John Skaugen in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Search for other papers by Seungwon Kim in
Google Scholar
PubMed
UPMC Hillman Cancer Center, Department of Oncology, Pittsburgh, Pennsylvania, USA
Search for other papers by Robert L Ferris in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Somak Roy in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
molecularly identified thyroidal metastasis of renal cell carcinoma and genetic alterations detected in FNAs by ThyroSeq testing. Case Age (y); gender Nodule size (cm) BCC Cytologic features a Multiple nodules USG History of RCC
Search for other papers by Giovanna Maria Pierantoni in
Google Scholar
PubMed
Search for other papers by Palma Finelli in
Google Scholar
PubMed
Search for other papers by Emanuele Valtorta in
Google Scholar
PubMed
Search for other papers by Daniela Giardino in
Google Scholar
PubMed
Search for other papers by Ornella Rodeschini in
Google Scholar
PubMed
Search for other papers by Francesco Esposito in
Google Scholar
PubMed
Search for other papers by Marco Losa in
Google Scholar
PubMed
Search for other papers by Alfredo Fusco in
Google Scholar
PubMed
Search for other papers by Lidia Larizza in
Google Scholar
PubMed
-functioning pituitary adenomas (NFPAs). The genesis of pituitary tumors is still under investigation since the genetic alterations of the pituicytes themselves, hypothalamic dysregulation and locally produced growth factors have not been integrated in a multistep model
Search for other papers by Glenn T G Chang in
Google Scholar
PubMed
Search for other papers by Mila Jhamai in
Google Scholar
PubMed
Search for other papers by Wytske M van Weerden in
Google Scholar
PubMed
Search for other papers by Guido Jenster in
Google Scholar
PubMed
Search for other papers by Albert O Brinkmann in
Google Scholar
PubMed
-repressible apoptosis gene. Apoptosis 7 13 –21. Cher ML , Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB & Jensen RH 1996 Genetic alterations in untreated metastases and androgen-independent prostate cancer
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Angel Chao in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Huei-Jean Huang in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Chiao-Yun Lin in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Chia-Hwa Lee in
Google Scholar
PubMed
Search for other papers by Chien-Hsing Lin in
Google Scholar
PubMed
Department of Obstetrics and Gynecology, New Taipei Municipal Tu Cheng Hospital, New Taipei City, Taiwan
Search for other papers by An-Shine Chao in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Chyong-Huey Lai in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Ting-Chang Chang in
Google Scholar
PubMed
Gynecologic Cancer Research Center, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Kai-Yun Wu in
Google Scholar
PubMed
Department of Anatomic Pathology, Linkou Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Taoyuan, Taiwan
Search for other papers by Ren-Chin Wu in
Google Scholar
PubMed
patients (#SCT-01 and #SCT-03) had negative results on the TSO500 assay and underwent confirmatory testing with WES. The genetic alterations identified in the seven SCTs NOS samples are summarized in Table 2 . In brief, mutations in two hypoxia
Search for other papers by Arivarasan Karunamurthy in
Google Scholar
PubMed
Search for other papers by Federica Panebianco in
Google Scholar
PubMed
Search for other papers by Susan J Hsiao in
Google Scholar
PubMed
Search for other papers by Jennie Vorhauer in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Simion Chiosea in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
encapsulated, is a typical phenotype of EIF1AX -mutated PTC. Since the follicular variant of PTC is known to share genetic alterations with other follicular-patterned thyroid tumors, that is, FTC and FA ( Nikiforov & Nikiforova 2011 ), it was important to
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by Laura Valerio in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Agnese Biagini in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Virginia Cappagli in
Google Scholar
PubMed
Search for other papers by Letizia Pieruzzi in
Google Scholar
PubMed
Search for other papers by Carlotta Giani in
Google Scholar
PubMed
Search for other papers by Elena Sabini in
Google Scholar
PubMed
Search for other papers by Paolo Passannati in
Google Scholar
PubMed
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Search for other papers by Benedetta Pontillo-Contillo in
Google Scholar
PubMed
Search for other papers by Valentina Battaglia in
Google Scholar
PubMed
Search for other papers by Salvatore Mazzeo in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
-RAS mutations are found in a relatively small percentage of PTCs, they represent the most frequent genetic alterations in FTCs, and they are also significantly present in PDTCs and ATCs ( Xing 2013 ). Other common genetic alterations in FTCs are PTEN deletion
Search for other papers by Sunmi Park in
Google Scholar
PubMed
Search for other papers by Mark C Willingham in
Google Scholar
PubMed
Search for other papers by Jun Qi in
Google Scholar
PubMed
Search for other papers by Sheue-Yann Cheng in
Google Scholar
PubMed
reported that genetic alterations in the PI3K-AKT pathway play a critical role in thyroid tumorigenesis and progression ( Hou et al . 2007 , Wang et al . 2007 , Xing 2010 ). Furthermore, association of PTEN methylation with the activating genetic
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
of tumor classification schemes. Together with the identification of novel genetic alterations, these results have profound implications for the treatment of cancer patients. Tumors of endocrine organs are similarly genomic diseases. Compared to